Teladoc Health, Inc. (TDOC)
Automate Your Wheel Strategy on TDOC
With Tiblio's Option Bot, you can configure your own wheel strategy including TDOC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TDOC
- Rev/Share 14.391
- Book/Share 7.9242
- PB 0.9402
- Debt/Equity 0.7412
- CurrentRatio 2.6976
- ROIC -0.0995
- MktCap 1322176867.0
- FreeCF/Share 1.4606
- PFCF 5.1527
- PE -5.8537
- Debt/Assets 0.3585
- DivYield 0
- ROE -0.156
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | TDOC | BMO Capital Markets | -- | Market Perform | -- | $8 | Nov. 13, 2025 |
| Initiation | TDOC | Mizuho | -- | Neutral | -- | $10 | July 25, 2025 |
| Reiterated | TDOC | Jefferies | -- | Hold | $8 | $10 | Sept. 17, 2024 |
News
Why Is Teladoc (TDOC) Down 14.8% Since Last Earnings Report?
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Negative
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
Read More
Does Teladoc's Acquisition Strategy Boost Growth and Global Footprint?
Published: November 21, 2025 by: Zacks Investment Research
Sentiment: Positive
TDOC's steady stream of acquisitions is expanding its global reach and lifting growth across key segments in 2025.
Read More
TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio?
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
TDOC and LFMD face contrasting paths as telehealth demand climbs, with fundamentals and growth plans shaping which stock stands out.
Read More
TDOC Partners With TytoCare to Expand At-Home Exam Capabilities
Published: November 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Teladoc Health deepens its virtual care reach by adding TytoCare's at-home exam tech to Primary360 and 24/7 Care starting in 2026.
Read More
TytoCare Integrates With Teladoc Health to Augment Virtual Primary and Urgent Care
Published: November 18, 2025 by: PRNewsWire
Sentiment: Neutral
TytoCare's FDA-cleared home diagnostic technology will be integrated with Teladoc Health's Primary360 and 24/7 Care programs, expanding high-quality remote care capabilities in-home capabilities NEW YORK , Nov. 18, 2025 /PRNewswire/ -- TytoCare, the leading virtual care company enabling in-home, clinical-grade physical exams, today announces an integration with Teladoc Health (NYSE: TDOC), the global leader in virtual care. This collaboration integrates TytoCare's Home Smart Clinic with Teladoc Health's 24/7 Care and Primary360 primary care programs, using advanced home diagnostic technology to provide clinical insights to virtual care clinicians.
Read More
Is Teladoc Health Accelerating Growth Through Global Expansion?
Published: November 17, 2025 by: Zacks Investment Research
Sentiment: Positive
TDOC accelerates global growth as expanding international operations and rising overseas revenues bolster its profitability outlook.
Read More
Teladoc Health's Q3 Loss Widens Y/Y on Weak BetterHelp Unit
Published: November 11, 2025 by: Zacks Investment Research
Sentiment: Negative
TDOC posts wider year-over-year loss in Q3 as BetterHelp segment stumbles, but gains in international revenues help cushion the blow.
Read More
How is Teladoc Health Placed in the Growing Telemedicine Market?
Published: November 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Teladoc Health is expanding its AI-powered virtual care capabilities as the telemedicine market surges toward massive U.S. growth.
Read More
How to Play Teladoc Health Stock Post Q3 Results: Buy, Hold or Sell?
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Teladoc Health's Q3 results beat estimates, but revenues dipped and losses widened, attributed to soft performance at BetterHelp.
Read More
Wall Street's Insights Into Key Metrics Ahead of Teladoc (TDOC) Q3 Earnings
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Teladoc (TDOC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Read More
These 3 stocks are primed for big moves after earnings this week
Published: October 28, 2025 by: Invezz
Sentiment: Neutral
Wall Street is bracing for a volatile week as several high-profile companies prepare to release third-quarter earnings, with options markets signaling sharp price swings ahead.
Read More
Teladoc (TDOC) Soars 10.0%: Is Further Upside Left in the Stock?
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Teladoc (TDOC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Read More
Teladoc (TDOC) Expected to Beat Earnings Estimates: Should You Buy?
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Teladoc (TDOC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Teladoc (TDOC) Recently Broke Out Above the 20-Day Moving Average
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Teladoc (TDOC) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TDOC crossed above the 20-day moving average, suggesting a short-term bullish trend.
Read More
Teladoc (TDOC) Just Reclaimed the 200-Day Moving Average
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
From a technical perspective, Teladoc (TDOC) is looking like an interesting pick, as it just reached a key level of support. TDOC recently overtook the 200-day moving average, and this suggests a long-term bullish trend.
Read More
Teladoc Health Expands Clarity Platform With Workplace Safety Tool
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
TDOC enhances its Clarity platform with an AI-driven tool to help hospitals combat rising workplace violence incidents.
Read More
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Teladoc (TDOC)
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Teladoc (TDOC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Read More
3 Medical Service Industry Stocks Poised to Counter Workforce Issues
Published: October 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Here are three resilient medical services stocks, Labcorp, Charles River Laboratories and Teladoc, that are poised to outperform amid staffing shortages and digital healthcare growth.
Read More
All You Need to Know About Teladoc (TDOC) Rating Upgrade to Buy
Published: October 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Teladoc (TDOC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Strength Seen in Teladoc (TDOC): Can Its 6.3% Jump Turn into More Strength?
Published: October 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Teladoc (TDOC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Read More
Why Is Teladoc (TDOC) Up 4.6% Since Last Earnings Report?
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
Read More
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Negative
TDOC posts narrower Q2 loss and trims costs, but shares dip as U.S. revenues and visit volumes decline.
Read More
Teladoc Health: Still Struggling To Find A Catalyst
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Positive
Teladoc Health remains a deep value play at $7, trading at just 5-6x EBITDA, but lacks a clear growth catalyst. Revenue and user metrics are declining across core segments, with BetterHelp and Chronic Care both losing momentum and failing to innovate. Recent acquisitions (UpLift, Catapult Health) have not meaningfully expanded Teladoc's platform or addressed its reliance on basic telehealth connections.
Read More
Teladoc Health Earnings: Not Dead Yet
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Positive
Teladoc's Q2 2025 earnings reaffirm strong free cash flow guidance, with the potential to reach $220 million in the next twelve months. Despite an attractive 7x next year's free cash flow valuation, revenue growth remains stagnant and threatens the bull case. Profitability and an improving balance sheet keep me tepidly bullish, but lack of growth and competitive pressures are major risks.
Read More
Teladoc Health, Inc. (TDOC) Q2 2025 Earnings Call Transcript
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Neutral
Teladoc Health, Inc. Q2 2025 Earnings Conference Call July 29, 2025 4:30 PM ET Company Participants Charles Divita - CEO & Director Mala Murthy - Chief Financial Officer Michael Minchak - Vice President of Investor Relations Conference Call Participants Sarah Elizabeth James - Cantor Fitzgerald & Co., Research Division Charles Rhyee - TD Cowen, Research Division Daniel R. Grosslight - Citigroup Inc., Research Division David Harrison Roman - Goldman Sachs Group, Inc., Research Division Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division Jailendra P.
Read More
Teladoc (TDOC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
Teladoc (TDOC) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.28 per share a year ago.
Read More
HIMS vs. TDOC: Which Direct-to-Consumer Health Stock Wins Now?
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Hims & Hers and Teladoc Health are reshaping virtual care, but which has the edge in earnings growth and strategic expansion? Let's see.
Read More
Teladoc (TDOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Negative
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
About Teladoc Health, Inc. (TDOC)
- IPO Date 2015-06-30
- Website https://www.teladochealth.com
- Industry Medical - Healthcare Information Services
- CEO Charles Divita III,
- Employees 4620